SLE

Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic, progressive, systemic

inflammatory disease affecting multiple organs and systems

autoimmune in nature, meaning the body’s immune system mistakenly attacks

its own tissues, resulting in inflammation, tissue damage, and dysfunction of
major organs.

SLE can flare up (active disease) or go into remission (symptom-free periods),

but the disease is lifelong and progressive, meaning it worsens over time if not
managed properly.

Connective tissue and fibrin deposits accumulate on collagen fibers (main

components of connective tissues) and within organs, particularly in the

SLE 1
 blood vessels, pleura (lining around the lungs), lymph nodes, and
gastrointestinal (GI) tract.

These deposits lead to necrosis (cell death) and inflammation, damaging the
surrounding tissues.

When the immune system is overactive, as in autoimmune diseases like

SLE, it mistakenly attacks healthy tissues.

This immune response leads to the release of proteins, including fibrin,

which can accumulate on collagen fibers. (Collagen is a protein that
gives structure to connective tissues in organs)

These deposits can build up in blood vessels, the pleura, lymph nodes,
and GI tract. When this happens, the normal function of these tissues is
disrupted. For example, in blood vessels, these deposits can narrow the
vessel walls, leading to reduced blood flow and tissue damage.

Fibrin and connective tissue deposits in blood vessels can obstruct

or narrow the vessel → restricting blood flow to tissues and organs →
blood flow is reduced → ischemia → hypoxia

fibrin and other proteins in tissues trigger an immune response →

chronic inflammation → Inflammatory cells release chemicals, such as
cytokines and free radicals, which can damage healthy cells in the
surrounding area

As the deposits build up, they trigger inflammation. Over time, this
inflammation can become chronic, causing surrounding cells to die
(necrosis). Necrosis can further damage the tissue, worsening the
problem.

When this process occurs in blood vessels, it can reduce blood supply to
tissues, leading to organ dysfunction

SLE is called systemic because it can affect multiple systems throughout the
body, such as the skin, joints, kidneys, heart, lungs, nervous system, and
blood. The disease can range from mild to life-threatening depending on the
organs involved.

Although there is no cure for SLE, patients can experience periods of

remission if they manage their condition properly through lifestyle

SLE 2
 modifications and medication adherence.

Causes

Immune Dysregulation

In SLE, the immune system, which defends the body against harmful
pathogens, malfunctions and starts attacking healthy tissues. This
abnormal response occurs because of a defect in immune regulation
mechanisms.

Normally, the immune system differentiates between foreign invaders and

the body's own tissues, but in SLE, this self-tolerance is lost. The body
produces autoantibodies, which target its own cells and proteins, leading
to widespread inflammation and tissue damage.

Genetic Component

SLE. Studies have shown that individuals with a family history of

autoimmune diseases, such as lupus, rheumatoid arthritis, or multiple
sclerosis, are at higher risk.

Several genes are thought to play a role in predisposing individuals to

immune dysregulation. These genetic factors may affect how the immune
system reacts to environmental triggers, leading to abnormal immune
responses.

SLE 3
 Environmental Triggers

Infections (such as viral infections)

Infections, especially viral infections, can activate the immune system.

In individuals predisposed to lupus, these infections may cause the
immune system to become overactive, leading to autoimmune
reactions

Certain viral infections, like Epstein-Barr virus (EBV), have been linked
to lupus → The immune system's response to viral infections can
create molecular mimicry, where immune cells mistake the body’s
own tissues for the virus, leading to an autoimmune attack.

Ultraviolet (UV) light exposure (especially from the sun)

UV exposure can cause skin cells to die more rapidly, releasing their
contents (including nuclear material) into the bloodstream. In people
with lupus, the immune system recognizes these released
components as foreign, triggering an autoimmune response. UV
light also promotes inflammatory responses that worsen lupus
symptoms, such as rashes and joint pain.

Hormonal changes, particularly in women, who are more commonly

affected by lupus

Estrogen can enhance immune responses, potentially increasing the

risk of the immune system becoming overactive

Certain medications (drug-induced lupus)

Medications such as hydralazine (used for high blood pressure) and

procainamide (used for heart arrhythmias) can trigger lupus-like
symptoms. These drugs may alter the immune system by causing an
abnormal immune response, which leads to the production of
autoantibodies that attack healthy cells.

Assessment
Butterfly (Malar) Rash:

SLE 4
 butterfly-shaped erythema that appears across the bridge of the nose
and cheeks. It is photosensitive, meaning it worsens with sun exposure.

Discoid Rash:

Discoid lupus erythematosus (DLE) is characterized by dry, scaly, raised

patches on the face or upper body. These patches may lead to scarring
as the disease progresses.

Fever, Fatigue, and Malaise:

Fever, weakness, and fatigue are common symptoms during flares,

resulting from the systemic inflammation caused by the immune system
attacking the body.

Photosensitivity:

Patients with SLE often experience photosensitivity, meaning exposure to

sunlight or UV rays triggers rashes or exacerbates systemic symptoms.

Joint Pain (Arthralgia):

Joint pain or arthritis is very common in SLE, affecting multiple joints,

particularly the small joints of the hands, wrists, and knees. Unlike
rheumatoid arthritis, the joint involvement in SLE is non-erosive, meaning
it doesn’t cause permanent joint damage in most cases.

SLE 5
 Systemic Symptoms:

Anemia: SLE commonly causes anemia due to chronic inflammation and

possible bone marrow suppression.

Palmar Erythema: Redness of the palms can be seen in some patients due
to inflammation.

Labs
Antinuclear Antibody (ANA) Test: This is a highly sensitive marker for SLE.
More than 95% of patients with SLE will have a positive ANA test, though it is
not specific to SLE.

detects antinuclear antibodies in the blood. These are autoantibodies

that target substances found in the nucleus of cells. In autoimmune
diseases like SLE, the immune system mistakenly produces these
antibodies that attack the body’s own cells.

While the ANA test is highly sensitive, it is not specific to SLE. This
means that a positive ANA test result does not confirm a diagnosis of
lupus.

In patients with SLE, the presence of ANA suggests that the immune
system is attacking its own tissues, contributing to the inflammation and
tissue damage seen in lupus. However, further testing is required to
confirm SLE.

Elevated ESR and C-reactive protein (CRP): These indicate systemic

inflammation and help monitor disease activity.

Anti-dsDNA (Anti-double stranded DNA)

SLE 6
 Anti-dsDNA test is highly specific for Systemic Lupus Erythematosus
(SLE) and is particularly useful in diagnosing active disease.

This test is especially relevant because these antibodies tend to correlate

with disease activity, meaning higher levels are often seen during flares,
particularly when there is kidney involvement (lupus nephritis)

Anti-Smith (Sm) Antibodies

The Anti-Smith antibodies target specific proteins in the nucleus of cells

(called small nuclear ribonucleoproteins or snRNPs), which are involved in
splicing RNA. These antibodies are almost exclusive to SLE and rarely
found in other autoimmune diseases, making them a definitive marker for
lupus when present.

Anti-Smith antibodies remain relatively constant over time. This means

that once Anti-Smith antibodies are present, they usually continue to be
detectable regardless of how active or inactive the disease is at a
particular time

Nursing Interventions
Skin Care

Patients with SLE often have fragile skin due to rashes and medication
side effects (e.g., corticosteroids). Asses for breakdown, ulcers, or
infections.

Use mild soap: Harsh or perfumed soaps can irritate sensitive skin. A
gentle, fragrance-free soap is preferred.

Steroid creams or antimalarial medications like hydroxychloroquine can

help reduce inflammation and control skin symptoms.

Energy Conservation:

Educate the patient about balancing rest and activity. Patients should
avoid overexertion and manage fatigue by pacing activities and allowing
for frequent rest periods.

SLE 7
 Patients with SLE often experience chronic fatigue. Advising them on
energy conservation strategies is crucial for improving their quality of life.

Nutritional Support:

High-vitamin, high-iron diet: If anemia is present, a diet rich in iron and

vitamin C is important to support red blood cell production.

High-protein diet: For patients without kidney involvement, a high-protein

diet helps maintain muscle mass and support healing.

Monitor kidney function: Lupus nephritis is a serious complication of SLE

that can lead to kidney failure. Monitor for proteinuria and red cell casts
in the urine.

Medications:

Corticosteroids: These reduce inflammation but come with side effects

such as fluid retention, osteoporosis, and increased infection risk.
Monitor for fluid overload (e.g., daily weights, intake and output).

Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs help with joint

pain and inflammation but should be used cautiously due to the risk of
kidney damage.

Hydroxychloroquine: This is an antimalarial drug used to treat skin and

joint symptoms. Patients need regular eye exams as hydroxychloroquine
can cause retinal toxicity.

Immunosuppressive agents: In severe cases, drugs like azathioprine or

cyclophosphamide may be used to suppress the immune response.

Monitor for Organ Involvement:

Lupus nephritis: Early kidney involvement is common, and patients must

be monitored for signs of kidney damage (e.g., protein in urine, rising
creatinine levels). This can lead to renal failure if not addressed early.

Inflammation caused by lupus can lead to damage in the structures

within the kidneys that filter waste from the blood (glomeruli).

Protein in the urine

SLE 8
 is one of the earliest indicators of kidney damage. In a healthy
kidney, proteins are too large to pass through the filtration system,
but inflammation in lupus nephritis damages the glomeruli, allowing
proteins to leak into the urine.

Hematuria

Elevated Creatinine

Due to the loss of protein in the urine, fluid can accumulate in the
body, leading to swelling

High blood pressure is common in lupus nephritis as the kidneys'

ability to regulate blood pressure diminishes

If lupus nephritis is not diagnosed early and properly managed, it

can progress to chronic kidney disease (CKD) or end-stage renal
disease (ESRD)

Cardiovascular disease: Patients with SLE are at high risk for coronary
artery disease (CAD), pericarditis, and hypertension due to chronic
inflammation.

Neurological involvement: Seizures, cognitive dysfunction, and neuritis

are possible. Early identification and management are critical.

Seizures in lupus are often related to inflammation in the brain's blood

vessels

Cognitive Dysfunction: Often referred to as "lupus fog," cognitive

dysfunction can include issues with memory, concentration,
attention, and problem-solving (Cognitive dysfunction may be caused
by chronic inflammation, cerebral vasculitis, or small infarcts in the
brain)

Neuritis: Neuritis refers to inflammation of the nerves, particularly the

peripheral nerves

Patient Education:

Patients should avoid direct sunlight and wear protective clothing and
sunscreen to prevent exacerbations of the disease.

SLE 9
 Plasmapheresis: This procedure can help remove autoantibodies and
immune complexes from the blood, reducing inflammation and organ
damage.

SLE can be emotionally overwhelming due to its chronic nature and

unpredictable flares. Nurses should provide psychosocial support and
refer patients to support groups.

Monitor for Complications:

Pleuritis and pericarditis: Inflammation of the lining of the lungs (pleura)

or heart (pericardium) can cause chest pain and difficulty breathing.

Anemia: Due to chronic disease and inflammation, anemia is common in

SLE. Administer iron supplements as prescribed.

Infection: Patients on immunosuppressive therapy or steroids have an

increased risk of infections.

SLE 10